Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice
出版年份 2015 全文链接
标题
Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice
作者
关键词
-
出版物
Frontiers in Genetics
Volume 6, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2015-07-22
DOI
10.3389/fgene.2015.00247
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rapamycin extends life span of Rb1+/− mice by inhibiting neuroendocrine tumors
- (2016) Carolina B. Livi et al. Aging-US
- Rapamycin extends life- and health span because it slows aging
- (2016) Mikhail V. Blagosklonny Aging-US
- Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice
- (2014) Jessica Nicks et al. NEUROBIOLOGY OF DISEASE
- Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
- (2014) Wilson C. Fok et al. PLoS One
- Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
- (2013) Richard A. Miller et al. AGING CELL
- Enhancement of mitochondrial function correlates with the extension of lifespan by caloric restriction and caloric restriction mimetics in yeast
- (2013) Kyung-Mi Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- eRapa Restores a Normal Life Span in a FAP Mouse Model
- (2013) P. Hasty et al. Cancer Prevention Research
- Rapamycin extends murine lifespan but has limited effects on aging
- (2013) Frauke Neff et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapamycin Extends Life and Health in C57BL/6 Mice
- (2013) Yiqiang Zhang et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- mTOR is a key modulator of ageing and age-related disease
- (2013) Simon C. Johnson et al. NATURE
- mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
- (2013) S. C. Johnson et al. SCIENCE
- Preserving Youth: Does Rapamycin Deliver?
- (2013) S. C. Johnson et al. Science Translational Medicine
- Rapamycin slows aging in mice
- (2012) John E. Wilkinson et al. AGING CELL
- Rapamycin-induced glucose intolerance: Hunger or starvation diabetes
- (2012) Mikhail V Blagosklonny CELL CYCLE
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
- (2012) Vladimir N. Anisimov et al. CELL CYCLE
- Rapamycin slows aging in mice
- (2012) Adam Spong et al. CELL CYCLE
- Rapamycin Ameliorates Age-Dependent Obesity Associated with Increased mTOR Signaling in Hypothalamic POMC Neurons
- (2012) Shi-Bing Yang et al. NEURON
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival
- (2012) F. J. Ramos et al. Science Translational Medicine
- Ageing in Drosophila: The role of the insulin/Igf and TOR signalling network
- (2010) Linda Partridge et al. EXPERIMENTAL GERONTOLOGY
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
- (2010) Richard A. Miller et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Rapamycin increases rDNA stability by enhancing association of Sir2 with rDNA in Saccharomyces cerevisiae
- (2010) Cheol Woong Ha et al. NUCLEIC ACIDS RESEARCH
- Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome
- (2010) A. Quintana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
- (2009) David E. Harrison et al. NATURE
- Mice with Mitochondrial Complex I Deficiency Develop a Fatal Encephalomyopathy
- (2008) Shane E. Kruse et al. Cell Metabolism
- A novel mutation in NDUFS4 causes Leigh syndrome in an Ashkenazi Jewish family
- (2008) S. L. Anderson et al. JOURNAL OF INHERITED METABOLIC DISEASE
- In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities
- (2008) S. Bisht et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More